Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa. (2018)
Attributed to:
Assessing new therapeutic opportunities linked to TCR signalling in mature T-cell lymphomas with unmet need
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2018.02863
PubMed Identifier: 30619256
Publication URI: http://europepmc.org/abstract/MED/30619256
Type: Journal Article/Review
Volume: 9
Parent Publication: Frontiers in immunology
ISSN: 1664-3224